Skip to content

Study · Not a test of the peptide alone · 2024

2 results

A model of subcutaneous pramlintide pharmacokinetics and its effect on gastric emptying: Proof-of-concept based on populational data.

Furió-Novejarque C, Sala-Mira I, Díez JL, Bondia J

Computer methods and programs in biomedicine6 Dec 2023Cited by 2 (Europe PMC)

PMID38064957 (opens in a new tab)DOI10.1016/j.cmpb.2023.107968 (opens in a new tab)PepBankPUB-38064957
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Pramlintide (Symlin) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Pramlintide (Symlin).

  1. 01Computer modelNot a test of Pramlintide (Symlin) aloneIn silicoOther

    The pramlintide computer model comprised four compartments and a plasma-dependent gastric emptying function.

    In plain wordsIn computer modelling, the pramlintide model used four compartments and a function linking gastric emptying to plasma pramlintide.

    Peptide
    Pramlintide (Symlin)
    Outcome
    Not applicableModel structure
    Study

    n: not reported in source

    Outcome group
    Pharmacokinetics · Pharmacology

    Source sentences

    Summary
    The final pramlintide model comprises four compartments and a function that modulates gastric emptying depending on plasma pramlintide.

    In this study, Pramlintide (Symlin) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Pramlintide (Symlin).

  2. 02Computer modelNot a test of Pramlintide (Symlin) aloneIn silicoOther

    The pramlintide computer model showed an appropriate fit to published population data.

    In plain wordsIn computer modelling, the pramlintide model fit published population data appropriately.

    Peptide
    Pramlintide (Symlin)
    Outcome
    Not applicableModel fit
    Study

    n: not reported in source

    Outcome group
    Pharmacokinetics · Pharmacology

    Source sentences

    Summary
    Results show an appropriate fit for the data.
    1 context sentence
    Summary · context
    The model is validated with published populational (clinical) data.

    In this study, Pramlintide (Symlin) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Pramlintide (Symlin).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:26 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.